Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia
|ラボの予算と財源：米国、欧州、アジア市場の見通し Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia|
|出版日: 2013年12月01日||ページ情報: 英文||
The Situation Life science research is weathering an economically challenging time, exacerbated by the federal budget sequestration in the United States and by continued austerity in Europe. Grant money from all sources-both public and private-is increasingly difficult to obtain, and pharmaceutical spending on R&D has flattened following years of solid gains. Add to this mix a decreased level of reimbursement for molecular diagnostic testing and a slow recovery from the “Great Recession” to establish the external macro economic environment that has led to a new normal that is defined by increasingly constrained budgets.
By contrast, developing nations in Asia-China in particular-are making significant investments in higher education, with a focus on science and technology, to include biotechnology. In addition, many global pharmaceutical and biopharmaceutical firms are establishing research centers in these countries, taking advantage of lower cost structures and the new availability of a well-trained work force. Our 2013 studies suggest that average laboratory budgets in Asia are larger than those in the United States and Europe. In this complex macroeconomic environment, life science suppliers are seeking guidance as to how to anticipate market trends in the United States, Europe and Asia in the coming year.
Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia will explore projected 2014 lab budgets by region and the implications of these findings for the life science tools market in the coming year. In this Q4 multi-sponsor report, we will provide an indepth exploration of anticipated lab spend for the year 2014. This primary and secondary research will enable suppliers to forecast demand, allocate resources and respond appropriately to the economies of a global market.
By leveraging a coalition of participating life science suppliers (Sponsors), this assignment will provide market data in aggregate as well as by region. The primary objective of this engagement will be for BioInformatics, LLC to provide
Sponsors with sources of funding, current spending and projected allocation of 2014 lab budgets in the United States and Europe. Additionally, current spending and projected allocation of 2014 lab budgets will be presented for Asia.
In order for BioInformatics, LLC to commence with the publication of this report, a minimum of six (6) Sponsors must commission this study.
The objective of this study is to assess sources of funding, the competitive landscape and market opportunities for life science tools companies. From the perspective of end-users, the goals of this assignment will be to:
1. Understand current sources of funding from government/ stimulus/private foundation grants, distribution time frame and how labs initiate applications for funding.
2. Compare and contrast FY2013 (actual), and FY2014 (projected) average lab budgets in total by broad product category, region and market segment; providing directional information for FY2014.
3.Estimate scientists' budget for purchases and anticipated purchases in instrumentation and consumables, examining trends across key product categories.
4. Assess how optimistic scientists are regarding funding and the future of life science research.
Top Four Lab Areas Most Affected by Current Economic Climate